Roes K - Search Results

1

Statistical analysis of Goal Attainment Scaling endpoints in randomised trials.

Urach S, Gaasterland C, Posch M, Jilma B, Roes K, Rosenkranz G, Van der Lee JH, Ristl R. Urach S, et al. Among authors: roes k. Stat Methods Med Res. 2019 Jun;28(6):1893-1910. doi: 10.1177/0962280218777896. Epub 2018 Jun 19. Stat Methods Med Res. 2019. PMID: 29921167 Free PMC article.

2

Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.

Boessen R, Knol MJ, Groenwold RH, Grobbee DE, Roes KC. Boessen R, et al. Clin Trials. 2012 Oct;9(5):578-87. doi: 10.1177/1740774512456454. Clin Trials. 2012. PMID: 23060319 Clinical Trial.

3

An analytical approach to assess the predictive value of biomarkers in Phase II decision making.

Nikolakopoulos S, van der Wal WM, Roes KC. Nikolakopoulos S, et al. J Biopharm Stat. 2013;23(5):1106-23. doi: 10.1080/10543406.2013.814377. J Biopharm Stat. 2013. PMID: 23957519

4

Level of evidence for promising subgroup findings in an overall non-significant trial.

Tanniou J, Tweel IV, Teerenstra S, Roes KC. Tanniou J, et al. Stat Methods Med Res. 2016 Oct;25(5):2193-2213. doi: 10.1177/0962280213519705. Epub 2014 Jan 20. Stat Methods Med Res. 2016. PMID: 24448444

5

Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review.

Nikolakopoulos S, Roes KC, van der Lee JH, van der Tweel I. Nikolakopoulos S, et al. Trials. 2014 Jul 8;15:274. doi: 10.1186/1745-6215-15-274. Trials. 2014. PMID: 25004909 Free PMC article. Review.

6

Directions for new developments on statistical design and analysis of small population group trials.

Hilgers RD, Roes K, Stallard N; IDeAl, Asterix and InSPiRe project groups. Hilgers RD, et al. Among authors: roes k. Orphanet J Rare Dis. 2016 Jun 14;11(1):78. doi: 10.1186/s13023-016-0464-5. Orphanet J Rare Dis. 2016. PMID: 27301273 Free PMC article.

7

Sequential designs with small samples: Evaluation and recommendations for normal responses.

Nikolakopoulos S, Roes KC, van der Tweel I. Nikolakopoulos S, et al. Stat Methods Med Res. 2018 Apr;27(4):1115-1127. doi: 10.1177/0962280216653778. Epub 2016 Jun 24. Stat Methods Med Res. 2018. PMID: 27342574

8

Rare disease registries: potential applications towards impact on development of new drug treatments.

Jansen-van der Weide MC, Gaasterland CMW, Roes KCB, Pontes C, Vives R, Sancho A, Nikolakopoulos S, Vermeulen E, van der Lee JH. Jansen-van der Weide MC, et al. Orphanet J Rare Dis. 2018 Sep 5;13(1):154. doi: 10.1186/s13023-018-0836-0. Orphanet J Rare Dis. 2018. PMID: 30185208 Free PMC article.

9

The POWER-tool: Recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design.

Gaasterland CMW, Jansen-van der Weide MC, Vroom E, Leeson-Beevers K, Kaatee M, Kaczmarek R, Bartels B, van der Pol WL, Roes KCB, van der Lee JH. Gaasterland CMW, et al. Among authors: roes kcb. Health Policy. 2018 Dec;122(12):1287-1294. doi: 10.1016/j.healthpol.2018.09.011. Epub 2018 Sep 21. Health Policy. 2018. PMID: 30274934 Free article.

10

Recommendations for the design of small population clinical trials.

Day S, Jonker AH, Lau LPL, Hilgers RD, Irony I, Larsson K, Roes KC, Stallard N. Day S, et al. Among authors: roes kc. Orphanet J Rare Dis. 2018 Nov 6;13(1):195. doi: 10.1186/s13023-018-0931-2. Orphanet J Rare Dis. 2018. PMID: 30400970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters